Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 15-Nov-24 5:29 PM View:  | Lawlor Augustine Chief Operating Officer | Leap Therapeutics, Inc. (LPTX) | 13-Nov-24 | Exercise (in-the money or at-the-money) | 2,136 | $2.82 | $6,023.52 | < 1% 681.41K to 683.54K | 5% |
| 15-Nov-24 5:31 PM View: | Cavanaugh James H Director | Leap Therapeutics, Inc. (LPTX) | 13-Nov-24 | Exercise (in-the money or at-the-money) | 213 | $2.82 | $600.66 | < 1% 261.84K to 262.05K | 5% |
| 15-Nov-24 5:30 PM View: | Onsi Douglas E CEO,CFO,Pres.,GC,Treas.&Sec. Director | Leap Therapeutics, Inc. (LPTX) | 13-Nov-24 | Exercise (in-the money or at-the-money) Duplicate | 2,136 | $2.82 | $6,023.52 | < 1% 749.97K to 752.1K | 5% |
| 15-Nov-24 5:28 PM View: | Miraelli Christopher Chairman of the Board Director | Leap Therapeutics, Inc. (LPTX) | 13-Nov-24 | Exercise (in-the money or at-the-money) Duplicate | 2,136 | $2.82 | $6,023.52 | < 1% 681.41K to 683.54K | 5% |
| 30-Jan-24 8:39 PM View: | Sirard Cynthia Chief Medical Officer | Leap Therapeutics, Inc. (LPTX) | 26-Jan-24 | Option Exercise | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 30-Jan-24 8:37 PM View: | Onsi Douglas E CEO,CFO,Pres.,GC,Treas.,&Sec. Director | Leap Therapeutics, Inc. (LPTX) | 26-Jan-24 | Option Exercise | 7,500 | -- | -- | 2% 480.63K to 488.13K | |
| 30-Jan-24 8:41 PM View: | O'Mahony John Mark Chief Manufacturing Officer | Leap Therapeutics, Inc. (LPTX) | 26-Jan-24 | Option Exercise | 5,000 | -- | -- | 100% 0 to 5.0K | |
| 30-Jan-24 8:38 PM View: | Lawlor Augustine Chief Operating Officer | Leap Therapeutics, Inc. (LPTX) | 26-Jan-24 | Option Exercise | 5,000 | -- | -- | < 1% 676.41K to 681.41K | |
| 30-Jan-24 8:42 PM View: | Miraelli Christopher Chairman of the Board Director | Leap Therapeutics, Inc. (LPTX) | 26-Jan-24 | Option Exercise | 5,000 | -- | -- | 1% 414.57K to 419.57K | |
| 21-Mar-23 4:05 PM View: | Onsi Douglas E CEO,CFO,Pres.,GC,Treas.,&Sec. Director | Leap Therapeutics, Inc. (LPTX) | 17-Mar-23 | Option Exercise | 660,606 | -- | -- | 16% 4.15M to 4.81M | |
| 28-Sep-21 5:48 PM View: | Beigene, Ltd. 10% Owner | Leap Therapeutics, Inc. (LPTX) | 24-Sep-21 | Private Purchase | 2,543,800 | $2.85 | $7,249,830.00 | 53% 4.8M to 7.35M | |
| 30-Dec-20 9:28 PM View: | Healthcare Ventures Viii, L... 10% Owner | Leap Therapeutics, Inc. (LPTX) | 28-Dec-20 | Disposition (other) | 2,618,410 | -- | -- | (100%) 2.62M to 0 | |
| 24-Jun-20 7:00 PM View: | Perceptive Advisors LLC 10% Owner | Leap Therapeutics, Inc. (LPTX) | 22-Jun-20 | Market Purchase | 1,750,000 | $2.00 | $3,500,000.00 | 26% 6.73M to 8.48M | 12% |
| 05-Feb-19 4:20 PM View: | Miraelli Christopher CEO, President, Chairman Director 10% Owner | Leap Therapeutics, Inc. (LPTX) | 05-Feb-19 | Purchase Duplicate | 571,428 | $1.75 | $999,999.00 | 9% 6.51M to 7.08M | |
| 05-Feb-19 4:21 PM View: | Lawlor Augustine Chief Operating Officer 10% Owner | Leap Therapeutics, Inc. (LPTX) | 05-Feb-19 | Purchase Duplicate | 571,428 | $1.75 | $999,999.00 | 9% 6.51M to 7.08M | |
| 05-Feb-19 4:19 PM View: | Healthcare Ventures Ix, L.P. 10% Owner | Leap Therapeutics, Inc. (LPTX) | 05-Feb-19 | Purchase | 571,428 | $1.75 | $999,999.00 | 16% 3.57M to 4.14M | |
| 05-Feb-19 4:22 PM View: | Onsi Douglas E CFO, GC, Treasurer & Secretary 10% Owner | Leap Therapeutics, Inc. (LPTX) | 05-Feb-19 | Purchase Duplicate | 571,428 | $1.75 | $999,999.00 | 15% 3.89M to 4.46M | |
| 16-Nov-17 1:45 PM View: | Lawlor Augustine Chief Operating Officer 10% Owner | Leap Therapeutics, Inc. (LPTX) | 14-Nov-17 | Purchase Duplicate | 1,057,770 | $6.09 | $6,436,520.00 | 19% 5.48M to 6.54M | |
| 16-Nov-17 1:45 PM View: | Miraelli Christopher CEO, President, COB Director 10% Owner | Leap Therapeutics, Inc. (LPTX) | 14-Nov-17 | Purchase Duplicate | 1,057,770 | $6.09 | $6,436,520.00 | 19% 5.48M to 6.54M | |
| 16-Nov-17 1:45 PM View: | Healthcare Ventures Ix, L.P. 10% Owner | Leap Therapeutics, Inc. (LPTX) | 14-Nov-17 | Purchase | 1,057,770 | $6.09 | $6,436,520.00 | 42% 2.52M to 3.57M | |
| 16-Nov-17 1:45 PM View: | Onsi Douglas E CFO, GC, Treasurer & Secretary 10% Owner | Leap Therapeutics, Inc. (LPTX) | 14-Nov-17 | Purchase Duplicate | 1,057,770 | $6.09 | $6,436,520.00 | 37% 2.86M to 3.92M |
